To verify that the antiproliferative effect of Namodenoson is indeed mediated via ADORA3, the two cell lines HepG2 (HCC cell line) and HUCCT1 (CCA cell line) were coincubated with MRE3008F20, a specific ADORA3 receptor antagonist. Here, ADORA3 is linked to cholangiocarcinoma.